The brucellosis market is expanding due to the rising incidence of brucellosis, especially in regions reliant on livestock. Recent developments include advancements in diagnostic technologies, such as PCR tests and serological assays, enabling early and accurate detection. Vaccination programs for brucellosis livestock have also seen improvements, with new vaccines offering better efficacy. Market analysis indicates growing demand for diagnostic kits, vaccines, and treatments, particularly in Asia-Pacific, Latin America, and Africa, where the disease burden is higher. Government initiatives, international collaborations, and increasing funding for R&D are helping to boost market growth. However, challenges such as underreporting, lack of awareness in rural regions, and the need for more effective treatments persist. Ongoing innovations and strategic partnerships are expected to further drive market expansion.
